← Eichor
Condition: Malignant Solid Neoplasm Synced from ClinicalTrials.gov · July 27, 2026

Recruiting studies: Malignant Solid Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05178472Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05371132Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Taizhou Mabtech Pharmaceutical Co.,Ltd · NCT06933069Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT05059678Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocia
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07216534Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07032298TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors
Phase 1 · 1 location(s) · Neowise Biotechnology · NCT07266298Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
Phase 1/Phase 2 · 1 location(s) · Vector Vitale LLC · NCT06506643Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME T
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04693377Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Phase 1/Phase 2 · 81 location(s) · Novartis Pharmaceuticals · NCT04104776Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Centr
Phase 1/Phase 2 · 2 location(s) · Roswell Park Cancer Institute · NCT06306638A Study of CRD3874-SI in People With Solid Tumors
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06021626N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Hefei Xinzhu Biological Technology Co., Ltd. · NCT07639450Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06043713A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Phase 1/Phase 2 · 19 location(s) · Tyligand Pharmaceuticals (Suzhou) Limited · NCT06385925Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant S
Phase 1/Phase 2 · 1 location(s) · Sinocelltech Ltd. · NCT06600022Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors
Phase 1 · 2 location(s) · West China Hospital · NCT07567222CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Phase N/A · 27 location(s) · University Health Network, Toronto · NCT04151342IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
Phase 2 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07483554A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07250386A Study of MT027 in Patients with Pleural Malignant Tumors
Phase 1 · 1 location(s) · Suzhou Maximum Bio-tech Co., Ltd. · NCT06726564Communication Issues in Patient and Provider Discussions of Immunotherapy
NA · 2 location(s) · Emory University · NCT05873608Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Phase N/A · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT05539677Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT03907475DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05722886Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1 · 2 location(s) · National Cancer Institute (NCI) · NCT04222413A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.